30175975|t|Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3beta Pathway.
30175975|a|BACKGROUND: Axonopathy is closely linked to the development of diabetic encephalopathy induced by type II diabetes (T2D). Berberine has been shown to cross the blood-brain barrier and holds promising effect for neuronal damage in diabetes. OBJECTIVE: The present study investigated the protective effect and the underlying mechanism of berberine on neuronal axonopathy in both in vitro and in vivo models. METHODS: High glucose/high fat diet and streptozotocin injection-induced T2D rat model was used. Berberine was administered p.o. to T2D rat model for 10 weeks. Morris water maze test, in vivo neuronal tracing, immunohistochemistry, and western blot analysis were performed to evaluate the protective effects of berberine in T2D-induced diabetic encephalopathy rats. Primary cultured neurons were used to further explore the underlying mechanisms in vitro. RESULTS: Berberine dramatically reduced blood glucose and serum insulin levels and alleviated insulin resistance. Berberine significantly attenuated memory impairment, axonopathy, and tau hyperphosphorylation, and also restored PI3K/Akt/GSK3beta signaling pathway in T2D rats. In vitro, berberine induced an increase in the phosphorylation of PI3K/Akt as well as GSK3beta in high glucose-treated primary neurons. Furthermore, berberine-induced PI3K/Akt activation also resulted in the dephosphorylation of tau protein, which could improve axonal transport impairment in high glucose-treated primary neurons. Pretreated neurons with LY294002, an inhibitor of PI3K, partially blocked berberine-inhibited tau phosphorylation and berberine-activated PI3K/Akt signaling pathway. CONCLUSIONS: Berberine exerts the protective effect against cognitive deficits by improving tau hyperphosphorylation and the axonal damage through restoring PI3K/Akt/GSK3beta signaling pathway.
30175975	0	9	Berberine	Chemical	MESH:D001599
30175975	50	60	Axonopathy	Disease	MESH:D016472
30175975	77	100	Diabetic Encephalopathy	Disease	MESH:C000721848
30175975	120	123	Akt	Gene	24185
30175975	124	132	GSK3beta	Gene	84027
30175975	154	164	Axonopathy	Disease	MESH:D016472
30175975	205	228	diabetic encephalopathy	Disease	MESH:C000721848
30175975	240	256	type II diabetes	Disease	MESH:D003924
30175975	258	261	T2D	Disease	MESH:D003924
30175975	264	273	Berberine	Chemical	MESH:D001599
30175975	353	368	neuronal damage	Disease	MESH:D009410
30175975	372	380	diabetes	Disease	MESH:D003920
30175975	478	487	berberine	Chemical	MESH:D001599
30175975	491	510	neuronal axonopathy	Disease	MESH:D009410
30175975	562	569	glucose	Chemical	MESH:D005947
30175975	588	602	streptozotocin	Chemical	MESH:D013311
30175975	621	624	T2D	Disease	MESH:D003924
30175975	625	628	rat	Species	10116
30175975	645	654	Berberine	Chemical	MESH:D001599
30175975	680	683	T2D	Disease	MESH:D003924
30175975	684	687	rat	Species	10116
30175975	859	868	berberine	Chemical	MESH:D001599
30175975	872	875	T2D	Disease	MESH:D003924
30175975	884	907	diabetic encephalopathy	Disease	MESH:C000721848
30175975	908	912	rats	Species	10116
30175975	1013	1022	Berberine	Chemical	MESH:D001599
30175975	1044	1057	blood glucose	Chemical	MESH:D001786
30175975	1098	1116	insulin resistance	Disease	MESH:D007333
30175975	1118	1127	Berberine	Chemical	MESH:D001599
30175975	1153	1170	memory impairment	Disease	MESH:D008569
30175975	1172	1182	axonopathy	Disease	MESH:D016472
30175975	1237	1240	Akt	Gene	24185
30175975	1241	1249	GSK3beta	Gene	84027
30175975	1271	1274	T2D	Disease	MESH:D003924
30175975	1275	1279	rats	Species	10116
30175975	1291	1300	berberine	Chemical	MESH:D001599
30175975	1352	1355	Akt	Gene	24185
30175975	1367	1375	GSK3beta	Gene	84027
30175975	1384	1391	glucose	Chemical	MESH:D005947
30175975	1430	1439	berberine	Chemical	MESH:D001599
30175975	1453	1456	Akt	Gene	24185
30175975	1579	1586	glucose	Chemical	MESH:D005947
30175975	1636	1644	LY294002	Chemical	MESH:C085911
30175975	1686	1695	berberine	Chemical	MESH:D001599
30175975	1730	1739	berberine	Chemical	MESH:D001599
30175975	1755	1758	Akt	Gene	24185
30175975	1791	1800	Berberine	Chemical	MESH:D001599
30175975	1838	1856	cognitive deficits	Disease	MESH:D003072
30175975	1903	1916	axonal damage	Disease	MESH:D001480
30175975	1940	1943	Akt	Gene	24185
30175975	1944	1952	GSK3beta	Gene	84027
30175975	Association	MESH:D001599	MESH:D003920
30175975	Positive_Correlation	MESH:D013311	MESH:D003924
30175975	Negative_Correlation	MESH:D001599	MESH:C000721848
30175975	Negative_Correlation	MESH:D001599	MESH:D016472
30175975	Association	MESH:D001480	84027
30175975	Negative_Correlation	MESH:C085911	MESH:D001599
30175975	Positive_Correlation	MESH:D001599	24185
30175975	Negative_Correlation	MESH:D001599	MESH:D003072
30175975	Negative_Correlation	MESH:D001599	MESH:D007333
30175975	Negative_Correlation	MESH:D001599	MESH:D009410
30175975	Association	24185	84027
30175975	Negative_Correlation	MESH:C085911	24185
30175975	Association	MESH:C000721848	84027
30175975	Association	MESH:D016472	24185
30175975	Positive_Correlation	MESH:D001599	MESH:D001480
30175975	Positive_Correlation	MESH:D001599	84027
30175975	Negative_Correlation	MESH:D001599	MESH:D001786
30175975	Association	MESH:D016472	84027
30175975	Negative_Correlation	MESH:D001599	MESH:D008569
30175975	Association	MESH:D003072	84027

